XML 44 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Changes in Equity - USD ($)
Share Capital
MVS
Share Capital
SVS
Share Capital
Treasury Shares
Share-Based Reserves
Other Reserves
Total Reserves
Accumulated Deficit
Total Curaleaf Holdings, Inc. Shareholders' Equity
Redeemable Non -Controlling Interest Contingency
Non-Controlling Interest
Redeemable Non-Controlling Interest
MVS
SVS
Total
Beginning Balance at Dec. 31, 2018     $ 657,525,000   $ 6,698,000 $ (153,459,000) $ (146,761,000) $ (65,666,000) $ 440,773,000 $ (2,957,000)   $ (2,174,000)     $ 435,642,000
Beginning Balance (in shares) at Dec. 31, 2018 122,170,705 335,292,331   (4,325,000)                      
Repurchase of shares       $ (883,000)         (883,000)           (883,000)
Repurchase of shares (in shares)   (147,900)                          
Exercise and forfeiture of stock options     5,125,000   (2,788,000)   (2,788,000)   2,337,000           2,337,000
Exercise and forfeiture of stock options (in shares)   7,071,331                          
Share-based compensation         16,607,000   16,607,000   16,607,000           16,607,000
Issuance of shares in connection with acquisitions     31,049,000           31,049,000           31,049,000
Issuance of shares in connection with acquisitions (in shares)   5,698,604                          
Non-controlling interest in connection with acquisitions                     $ 2,156,000       2,156,000
Conversion of MVS to SVS (in shares) (18,200,000) 18,200,000                          
Minority buyouts           (13,877,000) (13,877,000)   (13,877,000) 263,000         (13,614,000)
Net income (loss)               (67,244,000) (67,244,000)     (2,604,000)     (69,848,000)
Ending Balance (in shares) at Dec. 31, 2019 103,970,705 366,114,366   (5,208,000)                      
Ending Balance at Dec. 31, 2019     693,699,000   20,517,000 (167,336,000) (146,819,000) (132,910,000) 408,762,000 (2,694,000) 2,156,000 (4,778,000)     403,446,000
Exercise and forfeiture of stock options     12,902,000   (9,891,000)   (9,891,000)   3,011,000           3,011,000
Exercise and forfeiture of stock options (in shares)   9,052,775                          
Share-based compensation         22,386,000   22,386,000   22,386,000           22,386,000
Issuance of shares in connection with acquisitions     969,479,000           969,479,000           969,479,000
Issuance of shares in connection with acquisitions (in shares)   173,460,668                          
Issuance of shares in connection with private placement, net of issuance costs     30,236,000     (5,684,000) (5,684,000)   24,552,000           24,552,000
Issuance of shares in connection with private placement, net of issuance costs (in shares)   4,383,698                          
Issuance of shares in connection with license success fee     2,348,000           2,348,000           2,348,000
Issuance of shares in connection with license success fee (in shares)   245,629                          
Conversion of MVS to SVS (in shares) (10,000,000) 10,000,000                          
Minority buyouts   $ 6,163,920 45,748,000     (39,254,000) (39,254,000)   6,494,000     4,308,000     10,802,000
Non cash bonus         1,518,000   1,518,000   1,518,000           1,518,000
Non cash bonus (in shares)   410,084                          
Net income (loss)               (61,735,000) (61,735,000)   (63,000) $ 470,000     (61,328,000)
Ending Balance (in shares) at Dec. 31, 2020 93,970,705 569,831,140   (5,208,000)                 93,970,705 569,831,140  
Ending Balance at Dec. 31, 2020     $ 1,754,412,000   $ 34,530,000 $ (212,274,000) $ (177,744,000) $ (194,645,000) $ 1,376,815,000 $ (2,694,000) $ 2,093,000       $ 1,376,214,000